Angela Alamo Rosita A Condorelli Sandro La Vignera Aldo E Calogero
10.1177/2058738419843690
Int J Immunopathol Pharmacol
2019 Jan-Dec;33:2058738419843690.
alemtuzumab autoimmunity monoclonal antibody multiple sclerosis thyroid disease
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30968726/
Alemtuzumab / adverse effects Antineoplastic Agents, Immunological / adverse effects Autoimmune Diseases / chemically induced Hypothyroidism / chemically induced Multiple Sclerosis / drug therapy
Alemtuzumab / adverse effects Antineoplastic Agents, Immunological / adverse effects Autoimmune Diseases / chemically induced Hypothyroidism / chemically induced Multiple Sclerosis / drug therapy Case Reports Adult Autoimmune Diseases / diagnostic imaging Female Humans Hypothyroidism / diagnostic imaging Multiple Sclerosis / diagnostic imaging Antineoplastic Agents, Immunological Alemtuzumab
PMC6458661
30968726
Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis
2019